Anti-FOXP3抗体[mAbcam 22510] (ab22510)

发表研究结果有使用 ab22510?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab22510 被引用在 44 文献中.

  • Ma A  et al. Anti-inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells. Mol Med Rep 15:3615-3622 (2017). PubMed: 28440447
  • Shimizu K  et al. Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3(+) regulatory T cells in non-small cell lung cancer. Oncol Lett 14:1615-1620 (2017). PubMed: 28789387
  • Ameratunga M  et al. PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC. PLoS One 11:e0153954 (2016). IHC . PubMed: 27104612
  • Yi MH  et al. CD200R/Foxp3-mediated signalling regulates microglial activation. Sci Rep 6:34901 (2016). PubMed: 27731341
  • Yukawa T  et al. Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer. Oncol Rep 33:74-80 (2015). PubMed: 25338928
  • Gao Y  et al. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS One 10:e0137881 (2015). PubMed: 26367459
  • Kakavand H  et al. PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients. Clin Cancer Res 21:3140-8 (2015). PubMed: 25609064
  • Tarhini AA  et al. Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab. PLoS One 9:e87705 (2014). IHC-P ; Human . PubMed: 24498358
  • Zhuo C  et al. Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival. Mol Cancer 13:153 (2014). WB ; Human . PubMed: 24938080
  • Wheat R  et al. Inflammatory cell distribution in primary merkel cell carcinoma. Cancers (Basel) 6:1047-64 (2014). IHC-P ; Human . PubMed: 24961933
  • Magni S  et al. miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease. Am J Gastroenterol N/A:N/A (2014). PubMed: 25070052
  • Zhang X  et al. Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in rats. PLoS One 9:e114621 (2014). PubMed: 25474102
  • Tong C  et al. Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells. Int J Clin Exp Pathol 7:3166-73 (2014). PubMed: 25031736
  • Sbidian E  et al. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy. Clin Infect Dis 57:1648-55 (2013). Human . PubMed: 24065320
  • Germanidis G  et al. Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation. Front Immunol 4:207 (2013). PubMed: 23898331
  • Takenaka M  et al. FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis. Mol Clin Oncol 1:625-632 (2013). IHC . PubMed: 24649219
  • Kim M  et al. Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer. PLoS One 8:e53630 (2013). PubMed: 23382847
  • Yang J  et al. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling. World J Gastroenterol 18:2938-47 (2012). WB ; Human . PubMed: 22736917
  • deLeeuw RJ  et al. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res 18:3022-9 (2012). PubMed: 22510350
  • Sundin M  et al. Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? J Immunother 34:336-42 (2011). PubMed: 21499129
  • Engelmann P  et al. Characterization of human invariant natural killer T cells expressing FoxP3. Int Immunol 23:473-84 (2011). PubMed: 21708895
  • Mansfield AS  et al. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod Pathol 24:487-94 (2011). IHC-P ; Human . PubMed: 21151098
  • Speletas M  et al. Foxp3 expression in liver correlates with the degree but not the cause of inflammation. Mediators Inflamm 2011:827565 (2011). WB . PubMed: 21772667
  • Wolf D  et al. Comment on "Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice". J Immunol 184:4051 (2010). PubMed: 20368283
  • Matsumoto Y  et al. Expression of master regulators of helper T-cell differentiation in peripheral T-cell lymphoma, not otherwise specified, by immunohistochemical analysis. Am J Clin Pathol 133:281-90 (2010). PubMed: 20093238
  • Minoo P  et al. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 37:707-18 (2010). IHC-P ; Human . PubMed: 20664940
  • Heinze E  et al. Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo. Int J Oncol 35:167-73 (2009). WB ; Human . PubMed: 19513564
  • Richendollar BG  et al. Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors. Leuk Lymphoma 50:2005-12 (2009). IHC-P ; Human . PubMed: 19860626
  • Sweetenham JW  et al. Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study. Ann Oncol : (2009). PubMed: 19875761
  • Sakaki M  et al. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res 38:354-61 (2008). IHC-P ; Human . PubMed: 18021223
  • Tzankov A  et al. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93:193-200 (2008). IHC-P ; Human . PubMed: 18223287
  • Anraku M  et al. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 135:823-9 (2008). PubMed: 18374762
  • Woo YL  et al. FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies. J Clin Pathol 61:969-71 (2008). PubMed: 18413654
  • Kotakadi VS  et al. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis 29:1799-806 (2008). PubMed: 18567620
  • Bunnag S  et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 8:1423-33 (2008). IHC-P ; Human . PubMed: 18510637
  • Jang TJ Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors. Yonsei Med J 49:942-8 (2008). IHC-P ; Human . PubMed: 19108017
  • Eijkelkamp N  et al. G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice. Gut 56:847-54 (2007). WB ; Mouse . PubMed: 17229795
  • Polak ME  et al. Mechanisms of local immunosuppression in cutaneous melanoma. Br J Cancer 96:1879-87 (2007). IHC-P ; Human . PubMed: 17565341
  • Sasaki M  et al. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis. J Clin Pathol 60:1102-7 (2007). IHC-P ; Human . PubMed: 17158635
  • Yang ZZ  et al. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. Blood 110:2537-44 (2007). PubMed: 17615291
  • Mahic M  et al. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 177:246-54 (2006). WB ; Human . PubMed: 16785520
  • Oh U  et al. Reduced Foxp3 Protein Expression Is Associated with Inflammatory Disease during Human T Lymphotropic Virus Type 1 Infection. J Infect Dis 193:1557-66 (2006). PubMed: 16652285
  • Veldman C  et al. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 176:3215-22 (2006). PubMed: 16493082
  • Grant C  et al. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog 2:e33 (2006). Flow Cyt ; Human . PubMed: 16652169